These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 1461650)
41. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53. Ramqvist T; Magnusson KP; Wang Y; Szekely L; Klein G; Wiman KG Oncogene; 1993 Jun; 8(6):1495-500. PubMed ID: 8502475 [TBL] [Abstract][Full Text] [Related]
42. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax. Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521 [TBL] [Abstract][Full Text] [Related]
43. Suppression of tumorigenicity in temperature-sensitive mutants of embryonal carcinoma cells by induction of cell differentiation at non-permissive temperature. Sumi T; Nishina Y; Kosaka M; Sakuda M; Nishimune Y Int J Cancer; 1993 May; 54(2):333-7. PubMed ID: 8486432 [TBL] [Abstract][Full Text] [Related]
44. The kinetics of induction of Hox1.6 and C-jun mRNA during three different ways of inducing differentiation in teratocarcinoma F9 cells. Iwai SA; Nishina Y; Kosaka M; Sumi T; Doi T; Sakuda M; Nishimune Y In Vitro Cell Dev Biol Anim; 1995 Jun; 31(6):462-6. PubMed ID: 8589890 [TBL] [Abstract][Full Text] [Related]
46. Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9. Dony C; Kessel M; Gruss P Nature; 1985 Oct 17-23; 317(6038):636-9. PubMed ID: 2414665 [TBL] [Abstract][Full Text] [Related]
47. Isolation of mutants showing temperature-sensitive cell growth from embryonal carcinoma cells: control of stem cell differentiation by incubation temperatures. Nishimune Y; Nishina Y; Sumi T; Kosaka M; Takeda M; Matsumoto K; Matsushiro A; Sakuda M Biochem Biophys Res Commun; 1989 Nov; 165(1):65-72. PubMed ID: 2574037 [TBL] [Abstract][Full Text] [Related]
48. Induction of teratocarcinoma F9 cell differentiation with cis-diammine dichloroplatinum(II) (CDDP). Doi T; Sumi T; Nishina Y; Kosaka M; Iwai SA; Sakuda M; Nishimune Y Cancer Lett; 1995 Jan; 88(1):81-6. PubMed ID: 7850777 [TBL] [Abstract][Full Text] [Related]
49. Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. Lin D; Shields MT; Ullrich SJ; Appella E; Mercer WE Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9210-4. PubMed ID: 1409626 [TBL] [Abstract][Full Text] [Related]
50. c-myc regulation during retinoic acid-induced differentiation of F9 cells is posttranscriptional and associated with growth arrest. Dean M; Levine RA; Campisi J Mol Cell Biol; 1986 Feb; 6(2):518-24. PubMed ID: 3785153 [TBL] [Abstract][Full Text] [Related]
51. Gene regulation by temperature-sensitive p53 mutants: identification of p53 response genes. Buckbinder L; Talbott R; Seizinger BR; Kley N Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10640-4. PubMed ID: 7938006 [TBL] [Abstract][Full Text] [Related]
52. A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Lutzker SG; Levine AJ Nat Med; 1996 Jul; 2(7):804-10. PubMed ID: 8673928 [TBL] [Abstract][Full Text] [Related]
53. Expression of c-myc proto-oncogene during podophyllotoxin induced IW32 erythroleukemia cell differentiation. Yen YT; Wu RT; Tang SJ; Wang FF Biochem Biophys Res Commun; 1991 Sep; 179(3):1241-6. PubMed ID: 1930169 [TBL] [Abstract][Full Text] [Related]
54. Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes. Müller R; Wagner EF Nature; 1984 Oct 4-10; 311(5985):438-42. PubMed ID: 6541297 [TBL] [Abstract][Full Text] [Related]
55. CD40 activation mediates p53-dependent cell cycle regulation in human multiple myeloma cell lines. Teoh G; Tai YT; Urashima M; Shirahama S; Matsuzaki M; Chauhan D; Treon SP; Raje N; Hideshima T; Shima Y; Anderson KC Blood; 2000 Feb; 95(3):1039-46. PubMed ID: 10648420 [TBL] [Abstract][Full Text] [Related]
56. p53 is active in murine stem cells and alters the transcriptome in a manner that is reminiscent of mutant p53. Yan H; Solozobova V; Zhang P; Armant O; Kuehl B; Brenner-Weiss G; Blattner C Cell Death Dis; 2015 Feb; 6(2):e1662. PubMed ID: 25719246 [TBL] [Abstract][Full Text] [Related]
57. Changes of proliferative activity and phenotypes in spontaneous differentiation of a colon cancer cell line. Hara A; Hibi T; Yoshioka M; Toda K; Watanabe N; Hayashi A; Iwao Y; Saito H; Watanabe T; Tsuchiya M Jpn J Cancer Res; 1993 Jun; 84(6):625-32. PubMed ID: 8393433 [TBL] [Abstract][Full Text] [Related]
58. Complementation by wild-type p53 of interleukin-6 effects on M1 cells: induction of cell cycle exit and cooperativity with c-myc suppression. Levy N; Yonish-Rouach E; Oren M; Kimchi A Mol Cell Biol; 1993 Dec; 13(12):7942-52. PubMed ID: 8247009 [TBL] [Abstract][Full Text] [Related]
59. Murine teratocarcinoma and the developmental approach to neoplasia. Manes C Cancer Res; 1976 Nov; 36(11 Pt. 2):4206-7. PubMed ID: 975057 [No Abstract] [Full Text] [Related]
60. Loss of p53 expression in Myc-induced B lineage tumors. Scheuermann RH; Bauer SR Curr Top Microbiol Immunol; 1992; 182():493-9. PubMed ID: 1490390 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]